Caroline E Boeke
Overview
Explore the profile of Caroline E Boeke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serumondo J, Barebwanuwe P, Sheferaw E, Iyonizera J, Berabose C, Umuraza S, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39878504
Sofosbuvir/velpatasvir/voxilaprevir is recommended for hepatitis C virus (HCV) retreatment in those who fail initial treatment but is unavailable in resource-limited settings. We describe a government sofosbuvir/velpatasvir + ribavirin (SOF/VEL +...
2.
Tandon R, Boeke C, Sindhwani S, Chawla U, Govil P, Fernandes O, et al.
Indian J Public Health
. 2024 Sep;
68(3):387-395.
PMID: 39321227
Background: Hepatitis C virus (HCV) antibody prevalence in Punjab, India (0.56%) is higher than the national average (0.32%), but primary drivers of local transmission are unclear. Objectives: The objective of...
3.
Handanagic S, Shadaker S, Drobeniuc J, Tsereteli M, Alkhazashvili M, Adesigbin C, et al.
J Infect Dis
. 2023 Sep;
229(Supplement_3):S334-S341.
PMID: 37739781
In 2016, the World Health Organization introduced global targets for the care and management of hepatitis C virus (HCV) infection to eliminate hepatitis C as a public health threat by...
4.
Naing T, Yee W, Aung H, Oo K, Tint K, Boeke C, et al.
PLoS One
. 2023 May;
18(5):e0282585.
PMID: 37195968
Background: In Myanmar, 1.3 million people have been exposed to hepatitis C (HCV). However, public sector access to viral load (VL) testing for HCV diagnosis remains limited; ten near-point-of-care (POC)...
5.
Rutayisire R, Boeke C, Joseph J, Bansal N, Bigirimana N, Demke O, et al.
BMJ Open
. 2023 May;
13(4):e066776.
PMID: 37185639
Objectives: Reverse transcriptase PCR is the most sensitive test for SARS-CoV-2 diagnosis. However, the scale-up of these tests in low-income and middle-income countries (LMICs) has been limited due to infrastructure...
6.
Singla K, Boeke C, Tandon R, Chawla U, Witschi M, Mutreja K, et al.
Clin Liver Dis (Hoboken)
. 2023 Mar;
21(1):36-40.
PMID: 36937775
No abstract available.
7.
Boeke C, Adesigbin C, Adisa O, Agwuocha C, Akanmu M, Anartati A, et al.
BMJ Open
. 2022 Dec;
12(12):e062745.
PMID: 36576192
Objectives: Given limited data on factors associated with hepatitis C virus (HCV) treatment discontinuation and failure in low- and middle-income countries, we aimed to describe patient populations treated for HCV...
8.
Joseph J, Boeke C, Makadzange E, Sithole K, Maparo T, Mangwendeza P, et al.
AIDS
. 2022 Jan;
36(5):711-719.
PMID: 35025819
Objectives: Assess whether near-point-of-care (POC) viral load testing at the first antenatal care visit (ANC1) increased the proportion of women taking antiretroviral therapy who were virally suppressed at delivery through...
9.
Wang M, Boeke C, Rioja M, Maparo T, Banda C, Chavula C, et al.
AIDS
. 2021 Jul;
35(15):2531-2537.
PMID: 34310372
Objectives: Near-point-of-care (POC) testing for early infant diagnosis (EID) and viral load expedites clinical action and improves outcomes but requires capital investment. We assessed whether excess capacity on existing near-POC...
10.
Boeke C, Khan S, Walsh F, LeJeune C, Hettema A, Spiegelman D, et al.
HIV Med
. 2021 Jul;
22(9):854-859.
PMID: 34293243
Objectives: Universal Test and Treat (UTT) strategies are being adopted across sub-Saharan Africa based on clinical benefits to morbidity and mortality and to attain targets of the Joint United Nations...